"Targeting the CB2 receptor could be a therapeutic strategy to prevent or treat diseases like Crohn's disease [inflammation of the intestinal tract], liver cirrhosis, osteoarthritis, and atherosclerosis," said lead study author Jürg Gertsch.
read more | digg story
Subscribe to:
Post Comments (Atom)
-
Neurocardiology: The Brain in the Heart While the Laceys were doing their research in psychophysiology, a small group of cardiovas...
-
In an age of unprecedented volatility—marked by rapid technological disruption, economic uncertainty, and information overload—the timeles...
-
Abstract The trajectory of Sri Lankan history from 1505 to 1948 witnessed the systemic dismantling of an ancient, self-sufficient agrarian...
No comments:
Post a Comment